Patent · US Active

Nuclease with enhanced efficiency of genome editing

US11339408B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

APPLIED STEMCELL, INC. · US

Inventors

Ruby Yanru TSAI · Milpitas, US
Ling-jie KONG · Foster City, US
Jingyuan Cao · Changzhou City, CN

Key dates

Filing date	Aug 22, 2016
Grant date	May 24, 2022
Priority date	—
Expiry date	Jun 3, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/20
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure provides a composition comprising a site-specific nuclease domain capable of cleaving a target DNA sequence; and a sequence-specific DNA binding domain capable of specifically binding to a recognition DNA sequence, wherein the site-specific nuclease domain operably links to the sequence-specific DNA binding domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.